Volume 15, Number 7—July 2009
Rickettsia felis Infection in Man, France
Highlight and copy the desired format.
|EID||Renvoisé A, Joliot A, Raoult D. Rickettsia felis Infection in Man, France. Emerg Infect Dis. 2009;15(7):1126-1127. https://dx.doi.org/10.3201/eid1507.090029|
|AMA||Renvoisé A, Joliot A, Raoult D. Rickettsia felis Infection in Man, France. Emerging Infectious Diseases. 2009;15(7):1126-1127. doi:10.3201/eid1507.090029.|
|APA||Renvoisé, A., Joliot, A., & Raoult, D. (2009). Rickettsia felis Infection in Man, France. Emerging Infectious Diseases, 15(7), 1126-1127. https://dx.doi.org/10.3201/eid1507.090029.|
To the Editor: In August 2008, a 64-year-old man was admitted to the Salon-de-Provence Hospital, France. He had fever (39°C) and a maculopapular rash. No eschars or adenopathy were noted. The patient had a relatively mild illness; the only abnormal laboratory values were elevated aminotransferase levels (aspartate aminotransferase 85 U/L and alanine aminotransferase 135 U/L). The man was an agricultural worker who had originated from Algeria but at this time lived in a shelter in southern France. His potential for contact with dogs in his environment was noted, but no history of flea exposure was elicted. This disease was postulated to be rickettsiosis because no other cause for his fever and rash was evident. Doxycycline was then administered, and the patient rapidly improved.
Serum testing at the Unité des Rickettsies (Marseilles, France), using a multiple-antigen immunofluorescent assay (1), showed the following titers: spotted fever group (SFG) (e.g., Rickettsia felis, R. conorii, R. aeschlimannii, R. massiliae) 1,024 and 512 for immunoglobulin (Ig) G and IgM, respectively, and typhus group 512 and 256 for IgG and IgM, respectively. Serum was tested by real-time PCR by using a probe that enabled screening for spotted fever and a probe specific for R. felis; results were negative. A Western blot with cross-adsorption (2) showed R. felis as the causative agent (Figure). At a follow-up visit 3 months later, the patient had no signs or symptoms.
Rickettsiae were first described in the cat flea (Ctenocephalides felis) in 1918 and tentatively named R. ctenocephali. However, this work was overlooked until 1990, when an ELB agent was found in C. felis fleas by electron microscopy (3); the agent was demonstrated to be a Rickettsia-like organism. Results of subsequent studies were controversial because of suspected contamination of cultures. The species R. felis was formally validated by molecular criteria in 2001, and the reference strain was isolated in 2002 (4). R. felis has been demonstrated to belong to the SFG (5).
R. felis is distributed worldwide (Technical Appendix [PDF - 268 KB - 2 pages]), although it has not been found in the northern, coldest regions. The vectors described include fleas, ticks, and mites; however, the only currently recognized vector is the C. felis flea (6). The reported hosts for these vectors are mainly cats, dogs, and rodents. R. felis is the only SFG species that is transmitted by fleas. Studies have confirmed that R. felis in C. felis flea populations is mostly maintained by transstadial and transovarial transmission (7). Levels of R. felis infestation in C. felis fleas are variable, and the specific mechanisms of maintenance within each flea remain unknown. Prevalence is increased by fleas feeding on mammalian hosts infected with R. felis. Nevertheless, the precise relationship between the vector and the host remains unknown, and the mechanisms of rickettsial replication have not yet been examined (7).
We searched PubMed and found reports (case reports and seroprevalence studies) of 68 R. felis infections. Cases have been reported in the Americas, Asia, Tunisia, and Europe (Technical Appendix [PDF - 268 KB - 2 pages]). Such clinical cases rarely occur in warm countries, unlike the worldwide distribution of the bacteria, mentioned above. Reports of human infection with R. felis are rare, but the organism is frequently isolated from fleas.
We summarized the available clinical findings for 34 persons infected with R. felis: 32 had fever; 24, cutaneous rash (mostly maculopapular); 4, cutaneous eschar; 5, neurologic signs; 7, digestive symptoms; 3, cough without pneumonia; and 2, pneumonia. Clinical findings for R. felis are often confused with those found for patients with murine typhus or other febrile illnesses, and they appear to be more complex and more severe than initially thought.
R. felis infections can be diagnosed by serologic testing (1), molecular analysis, or a combination of each. Several molecular methods for detection of R. felis have focused on the presence of several genes, but real-time PCR assays are becoming increasingly useful (8). Serologic profiles for R. felis infections differ; cross-reactions with SFG rickettsiae as well as with SFG rickettsiae and R. typhi have been observed, but a lack of cross-reactions has also been observed (9). It has been noted (10) that when cross-reactions were observed between R. felis and both R. conorii and R. typhi, the infection was probably related to R. felis. When cross-reactions were observed between R. felis and only R. typhi, the causative agent was most probably of the typhus group.
R. felis infections occur globally and are linked to the worldwide distribution of vectors, but the occurrence is relatively rare when compared with the high frequency of R. felis infections related to flea infestation. Human infections remain poorly characterized and are apparently underappreciated, possibly because of the lack of specific signs and symptoms. Further characterization of the interactions between R. felis and fleas could elucidate the particular epidemiology and pathology of flea-borne spotted fever.
This work was supported by the French Centre National de la Recherche Scientifique.
- Rolain JM, Gouriet F, Brouqui P, Larrey D, Janbon F, Vene S, Concomitant or consecutive infection with Coxiella burnetii and tickborne diseases. Clin Infect Dis. 2005;40:82–8.
- La Scola B, Raoult D. Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases. J Clin Microbiol. 1997;35:2715–27.
- Schriefer ME, Sacci JB Jr, Dumler JS, Bullen MG, Azad AF. Identification of a novel rickettsial infection in a patient diagnosed with murine typhus. J Clin Microbiol. 1994;32:949–54.
- La Scola B, Meconi S, Fenollar F, Rolain JM, Roux V, Raoult D. Emended description of Rickettsia felis (Bouyer et al. 2001), a temperature-dependent cultured bacterium. Int J Syst Evol Microbiol. 2002;52:2035–41.
- Mehrej V, El Karkouri K, Raoult D. Whole genome-based phylogenetic analysis of rickettsiae. Clin Microbiol Infect. In press.
- Pérez-Osorio CE, Zavala-Velázquez JE, Arias León JJ, Zavala-Castro JE. Rickettsia felis as emergent global threat for humans. Emerg Infect Dis. 2008;14:1019–23.
- Reif KE, Stout RW, Henry GC, Foil LD, Macaluso KR. Prevalence and infection load dynamics of Rickettsia felis in actively feeding cat fleas. PLoS One. 2008;3:e2805.
- Henry KM, Jiang J, Rozmajzl PJ, Azad AF, Macaluso KR, Richards AL. Development of quantitative real-time PCR assays to detect Rickettsia typhi and Rickettsia felis, the causative agents of murine typhus and flea-borne spotted fever. Mol Cell Probes. 2007;21:17–23.
- Pérez-Arellano JL, Fenollar F, Angel-Moreno A, Bolaños M, Hernández M, Santana E, Human Rickettsia felis infection, Canary Islands, Spain. Emerg Infect Dis. 2005;11:1961–4.
- Znazen A, Rolain JM, Hammami A, Jemaa MB, Raoult D. Rickettsia felis infection, Tunisia. Emerg Infect Dis. 2006;12:138–40.
- Figure. Western blot after cross-adsorption with (left to right) Rickettsia conorii, R. massiliae, R. felis, and R. aeschlimannii. When cross-adsorption is performed with R. felis, the specific antigen-corresponding line disappears, which...
Technical AppendixCite This Article
Please use the form below to submit correspondence to the authors or contact them at the following address:
Didier Raoult, Unité des Rickettsies, CNRS-IRD UMR 6236-198, Université de la Méditerranée, Faculté de Médecine, 27 blvd Jean Moulin, 13385 Marseille CEDEX 5, France;
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 08, 2010
- Page last updated: December 08, 2010
- Page last reviewed: December 08, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)